» Articles » PMID: 25472824

Single Centre Experience of Hypothermic Machine Perfusion of Kidneys from Extended Criteria Deceased Heart-beating Donors: a Comparative Study

Overview
Journal Ir J Med Sci
Specialty General Medicine
Date 2014 Dec 5
PMID 25472824
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Kidneys from extended criteria donors are associated with higher rates of delayed graft function (DGF). Hypothermic machine perfusion (MP) for storage is associated with more favourable outcomes.

Methods: A retrospective analysis was performed in 93 patients where the kidney was stored using hypothermic MP (LifePort(®)) and compared to an age-matched control group where the kidney was stored in cold static storage (CSS) using University of Wisconsin solution.

Results: Median age was similar in both groups (59.2 years in MP vs 59.9 years in CSS, p = 0.5598). Mean cold storage time was 15.6 h in MP vs 17.9 h in CSS. Post transplant mean serum creatinine was as follows; MP group-144.7 μmol/L at 1 month; 138.3 μmol/L at 3 months and 129.5 μmol/L at 12 months. In the CSS group-163 μmol/L at 1 month; 154.9 μmol/L at 3 months and 140.2 μmol/L at 12 months. There was a statistically significant difference at 1 month (p = 0.0096) and 3 months (p = 0.0236). DGF was defined as the need for haemodialysis within 7 days post transplant. In the MP group, DGF occurred in 17.2 % patients with mean of 6 days (range 1-18). In the CSS group, 25.8 % patients with mean of 8.1 days (range 3-25). One-year graft survival rate was better in the MP group (97.85 vs 96.77 %).

Conclusion: Our experience to date recommends the use of hypothermic MP for storage of kidneys from extended criteria deceased heart-beating donors.

Citing Articles

Perfusion Techniques in Kidney Allograft Preservation to Reduce Ischemic Reperfusion Injury: A Systematic Review and Meta-Analysis.

Hasjim B, Sanders J, Alexander M, Redfield 3rd R, Ichii H Antioxidants (Basel). 2024; 13(6).

PMID: 38929081 PMC: 11200710. DOI: 10.3390/antiox13060642.


Outcomes of Kidney Perfusion Techniques in Transplantation from Deceased Donors: A Systematic Review and Meta-Analysis.

Ghoneima A, Sousa Da Silva R, Gosteli M, Barlow A, Kron P J Clin Med. 2023; 12(12).

PMID: 37373568 PMC: 10298857. DOI: 10.3390/jcm12123871.


Machine Perfusion for Abdominal Organ Preservation: A Systematic Review of Kidney and Liver Human Grafts.

Bellini M, Nozdrin M, Yiu J, Papalois V J Clin Med. 2019; 8(8).

PMID: 31443179 PMC: 6723966. DOI: 10.3390/jcm8081221.


Maximizing kidneys for transplantation using machine perfusion: from the past to the future: A comprehensive systematic review and meta-analysis.

Hameed A, Pleass H, Wong G, Hawthorne W Medicine (Baltimore). 2016; 95(40):e5083.

PMID: 27749583 PMC: 5059086. DOI: 10.1097/MD.0000000000005083.

References
1.
Kim J, Kim S, Joh J, Kwon C, Song S, Shin M . Is it safe to use a kidney from an expanded criteria donor?. Transplant Proc. 2011; 43(6):2359-62. DOI: 10.1016/j.transproceed.2011.05.040. View

2.
Port F, Bragg-Gresham J, Metzger R, Dykstra D, Gillespie B, Young E . Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation. 2002; 74(9):1281-6. DOI: 10.1097/00007890-200211150-00014. View

3.
Matsuno N, Konno O, Mejit A, Jyojima Y, Akashi I, Nakamura Y . Application of machine perfusion preservation as a viability test for marginal kidney graft. Transplantation. 2006; 82(11):1425-8. DOI: 10.1097/01.tp.0000243733.77706.99. View

4.
Ojo A, Hanson J, Meier-Kriesche H, Okechukwu C, Wolfe R, Leichtman A . Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001; 12(3):589-597. DOI: 10.1681/ASN.V123589. View

5.
Gomez V, Galeano C, Diez V, Bueno C, Diaz F, Burgos F . Economic impact of the introduction of machine perfusion preservation in a kidney transplantation program in the expanded donor era: cost-effectiveness assessment. Transplant Proc. 2012; 44(9):2521-4. DOI: 10.1016/j.transproceed.2012.09.065. View